DK2021794T3 - Anvendelse af protein S100A 12 som en markør for colorektal cancer - Google Patents

Anvendelse af protein S100A 12 som en markør for colorektal cancer

Info

Publication number
DK2021794T3
DK2021794T3 DK07725293.0T DK07725293T DK2021794T3 DK 2021794 T3 DK2021794 T3 DK 2021794T3 DK 07725293 T DK07725293 T DK 07725293T DK 2021794 T3 DK2021794 T3 DK 2021794T3
Authority
DK
Denmark
Prior art keywords
colorectal cancer
protein
marker
diagnosis
relates
Prior art date
Application number
DK07725293.0T
Other languages
Danish (da)
English (en)
Inventor
Andrea Geistanger
Michael Thierolf
Norbert Wild
Herbert Andres
Ursula Garczarek
Marie-Luise Hagmann
Johann Karl
Friedemann Krause
Michael Pfeffer
Wolfgang Rollinger
Michael Tacke
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of DK2021794T3 publication Critical patent/DK2021794T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4727—Calcium binding proteins, e.g. calmodulin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/795—Porphyrin- or corrin-ring-containing peptides
    • G01N2333/805—Haemoglobins; Myoglobins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205—Phosphotransferases in general
    • G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK07725293.0T 2006-05-19 2007-05-16 Anvendelse af protein S100A 12 som en markør for colorektal cancer DK2021794T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06010439 2006-05-19
PCT/EP2007/004378 WO2007134779A1 (en) 2006-05-19 2007-05-16 Use of protein s100a 12 as a marker for colorectal cancer

Publications (1)

Publication Number Publication Date
DK2021794T3 true DK2021794T3 (da) 2010-10-11

Family

ID=37087565

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07725293.0T DK2021794T3 (da) 2006-05-19 2007-05-16 Anvendelse af protein S100A 12 som en markør for colorektal cancer

Country Status (15)

Country Link
US (3) US20090286328A1 (enExample)
EP (1) EP2021794B8 (enExample)
JP (1) JP4942813B2 (enExample)
KR (1) KR101147586B1 (enExample)
CN (1) CN101449163B (enExample)
AT (1) ATE471512T1 (enExample)
AU (1) AU2007251933B2 (enExample)
BR (1) BRPI0711763A2 (enExample)
CA (1) CA2651709A1 (enExample)
DE (1) DE602007007209D1 (enExample)
DK (1) DK2021794T3 (enExample)
ES (1) ES2347485T3 (enExample)
MX (1) MX2008014482A (enExample)
PL (1) PL2021794T3 (enExample)
WO (1) WO2007134779A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10957217B2 (en) 2006-08-25 2021-03-23 Ronald A. Weitzman Population-sample regression in the estimation of population proportions
US11151895B2 (en) * 2006-08-25 2021-10-19 Ronald Weitzman Population-sample regression in the estimation of population proportions
ATE521894T1 (de) * 2007-11-20 2011-09-15 Hoffmann La Roche Verfahren zur beurteilung von kolorektalem krebs anhand einer stuhlprobe durch verwendung einer marker-kombination aus calprotectin und einem hämoglobin/haptoglobin-komplex
US9089540B2 (en) * 2008-01-31 2015-07-28 Keio University Method for determination of sensitivity to anti-cancer agent
EP2255198A4 (en) * 2008-02-15 2011-05-25 Mayo Foundation DETECTION OF NEOPLASM
WO2015067913A1 (en) 2013-11-07 2015-05-14 Diagnodus Limited Biomarkers
CN103033623A (zh) * 2012-12-10 2013-04-10 天津市协和医药科技集团有限公司 人m2型丙酮酸激酶化学发光免疫分析试剂盒及制备方法
CN104178562B (zh) * 2013-05-21 2018-11-09 生物梅里埃股份公司 一种大肠癌预后试剂盒
US10184154B2 (en) 2014-09-26 2019-01-22 Mayo Foundation For Medical Education And Research Detecting cholangiocarcinoma
EP3274440A4 (en) 2015-03-27 2019-03-06 Exact Sciences Corporation Detecting esophageal disorders
CN107271681A (zh) * 2017-06-05 2017-10-20 中国人民解放军沈阳军区总医院 血浆s100a12在st段抬高型心肌梗死早期诊断中的应用
CA3096391A1 (en) * 2018-04-12 2019-10-17 Board Of Regents, The University Of Texas System Biomarker for detecting cancer
EP4004549A1 (en) * 2019-07-23 2022-06-01 Stichting Het Nederlands Kanker Instituut- Antoni van Leeuwenhoek Ziekenhuis Progression markers for colorectal adenomas
JP7741067B2 (ja) * 2019-10-18 2025-09-17 エグザクト サイエンシーズ コーポレーション 複数の分析物を用いた糞便抗原検査

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61137064A (ja) * 1984-12-07 1986-06-24 Fujirebio Inc 大腸癌の予備スクリ−ニング方法
DE3838900A1 (de) * 1988-11-17 1990-05-23 Scheefers Borchel Ursula Pyruvatkinase-isoenzym typ m2 (tumor m2-pk) spezifische antikoerper/verfahren zu deren herstellung und deren verwendung
JPH02193071A (ja) * 1989-01-20 1990-07-30 Green Cross Corp:The ハプトグロビン―ヘモグロビン複合体測定用試薬キット及びそれを用いるハプトグロビン―ヘモグロビン複合体の測定法
JPH08238090A (ja) * 1995-03-06 1996-09-17 Jiro Hitomi 新規カルシウム結合タンパク
US20030175713A1 (en) * 2002-02-15 2003-09-18 Clemens Sorg Method for diagnosis of inflammatory diseases using CALGRANULIN C
JP2004198419A (ja) * 2002-12-13 2004-07-15 Bayer Healthcare Llc Ｔｉｍｐ１を用いた検出方法
EP1601969A2 (en) * 2003-03-08 2005-12-07 Auvation Ltd Markers for colorectal cancer
WO2005054508A2 (en) * 2003-12-01 2005-06-16 Ipsogen Gene expression profiling of colon cancer by dna microarrays and correlation with survival and histoclinical parameters
TR200700896T1 (tr) * 2004-07-23 2007-04-24 Aspenbio, Inc. Apandisit teşhisine ilişkin yöntem ve cihazlar

Also Published As

Publication number Publication date
WO2007134779A1 (en) 2007-11-29
US20170115294A1 (en) 2017-04-27
JP4942813B2 (ja) 2012-05-30
EP2021794B8 (en) 2010-08-18
ES2347485T3 (es) 2010-10-29
ATE471512T1 (de) 2010-07-15
AU2007251933A1 (en) 2007-11-29
CN101449163A (zh) 2009-06-03
KR101147586B1 (ko) 2012-08-23
CN101449163B (zh) 2014-06-25
CA2651709A1 (en) 2007-11-29
MX2008014482A (es) 2008-11-27
BRPI0711763A2 (pt) 2011-12-06
JP2009537798A (ja) 2009-10-29
US20150192587A1 (en) 2015-07-09
EP2021794A1 (en) 2009-02-11
DE602007007209D1 (de) 2010-07-29
EP2021794B1 (en) 2010-06-16
HK1133295A1 (en) 2010-03-19
PL2021794T3 (pl) 2010-12-31
KR20090007454A (ko) 2009-01-16
US20090286328A1 (en) 2009-11-19
AU2007251933B2 (en) 2011-05-12

Similar Documents

Publication Publication Date Title
DK2021794T3 (da) Anvendelse af protein S100A 12 som en markør for colorektal cancer
ATE554389T1 (de) Apex als marker für lungenkrebs
EA201600085A1 (ru) Набор для обнаружения соевого события syht0h2
EP2321430B8 (en) Method of evaluating oral cancer risk in human
MX2010005893A (es) Marcadores de expresion genica para enfermedad inflamatoria de intestino.
KR100711046B1 (ko) 대장암에 대한 마커로서의 니코틴아미드ｎ―메틸트랜스퍼라아제의 용도
DK2211180T3 (da) Anvendelse af protein SATB2 som markør til at skelne colorectal cancer fra andre former for cancer
JP2009537798A5 (enExample)
EP2019836A4 (en) PROCESSES, COMPOSITIONS AND KITS FOR DETECTING PROTEIN AGGREGATES
EP1949549A4 (en) PILOT SEQUENCE DETECTION
EP2075341A4 (en) METHOD FOR THE INVESTIGATION, DETERMINATION OR EVALUATION BY MEANS OF GENE EXPRESSION ANALYSIS
ATE476655T1 (de) Doxorubicin-immuntest
WO2015077382A3 (en) Combined cytology and molecular testing for early detection of esophageal adenocarcinoma
ATE468535T1 (de) Verwendung von nnmt als marker für lungenkrebs
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms
WO2010000467A8 (en) Asc as a marker for lung cancer
BRPI0520067A2 (pt) desenvolvimento de um ensaio de pcr em tempo real para a detecção de dna pneumocócico e diagnóstico da doença pneumocócica
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
BR112017009309A2 (pt) dispositivo de teste para medir a quantidade de analito em uma amostra fluida, método para fazer um dispositivo de teste para medir a quantidade de analito em uma amostra fluida, e método de utilização de um dispositivo de teste
ATE531822T1 (de) Diagnose von prostatakrebs
DE602004001994D1 (de) Verwendung des proteins masp als marker für kolorektale karzinome
EA200801533A1 (ru) Производные антрахинона в качестве маркирующих веществ для жидкостей
DK2274623T3 (da) Fremgangsmåde til diagnosticering af pulmonal arteriel hypertension
WO2005040806A3 (en) Use of protein asc as a marker for breast cancer
ATE426168T1 (de) Verwendung von asc als marker fur kolorektalkarzinome